Yoshiharu Motoo Selected Research

saiko-keishi-to (TJ10)

11/2014	Effect of Saikokeishito, a Kampo medicine, on hydrogen peroxide-induced premature senescence of normal human dermal fibroblasts.
1/2007	Suppressive effect of herbal medicine saikokeishito on acinar cell apoptosis in rat spontaneous chronic pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiharu Motoo Research Topics

Disease

36	Neoplasms (Cancer) 06/2022 - 10/2002
19	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 10/2002
9	Chronic Pancreatitis 07/2007 - 01/2002
6	Pancreatitis 01/2007 - 03/2002
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2006
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2019 - 01/2006
5	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2005
5	Prostatic Neoplasms (Prostate Cancer) 09/2017 - 10/2002
4	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 01/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 06/2022 - 06/2020
3	Fatigue 06/2022 - 10/2015
3	Anorexia 06/2022 - 10/2015
3	Obesity 09/2020 - 03/2010
3	Neoplasm Metastasis (Metastasis) 12/2017 - 11/2011
3	Adenocarcinoma of Lung 12/2017 - 12/2007
3	Fibrosis (Cirrhosis) 11/2014 - 10/2002
3	Liver Neoplasms (Liver Cancer) 12/2009 - 01/2006
3	Pathologic Constriction (Stenosis) 01/2006 - 01/2005
3	Pancreatic Diseases (Pancreatic Disease) 08/2005 - 10/2002
2	Peritoneal Neoplasms 01/2022 - 12/2017
2	Non-alcoholic Fatty Liver Disease 09/2021 - 09/2020
2	Body Weight (Weight, Body) 09/2021 - 01/2007
2	Disease Progression 06/2021 - 11/2003
2	Anemia 10/2015 - 07/2005
2	Neutropenia 04/2015 - 04/2012
2	Multiple Myeloma 12/2012 - 06/2011
2	Glioblastoma (Glioblastoma Multiforme) 03/2012 - 12/2009
2	Hyperthermia 09/2010 - 10/2009
2	Glucose Intolerance 03/2010 - 11/2009
2	Inflammation (Inflammations) 12/2009 - 11/2009
2	Carcinogenesis 12/2009 - 08/2007
2	Type 2 Diabetes Mellitus (MODY) 12/2009 - 01/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2009 - 11/2009
2	Autoimmune Pancreatitis 01/2008 - 08/2005
2	Anaphylaxis (Anaphylactic Shock) 12/2007 - 08/2007
2	Carcinoma (Carcinomatosis) 12/2006 - 11/2003
2	Thyroid Neoplasms (Thyroid Cancer) 09/2005 - 11/2003
1	Cachexia 06/2022
1	Myalgia 05/2022
1	Mucositis 05/2022
1	Arthralgia (Joint Pain) 05/2022
1	Ascites 01/2022
1	Choline Deficiency 09/2021
1	Exsanguination 09/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2003
8	Gemcitabine FDA Link 04/2015 - 03/2006
8	Nuclear Proteins (Protein, Nuclear)IBA 01/2013 - 07/2004
6	Messenger RNA (mRNA)IBA 06/2012 - 10/2002
5	SteroidsIBA 10/2019 - 10/2002
5	Pharmaceutical PreparationsIBA 12/2017 - 07/2004
5	Docetaxel (Taxotere)FDA Link 09/2017 - 10/2009
5	Glycogen Synthase KinasesIBA 01/2013 - 01/2006
5	Phosphotransferases (Kinase)IBA 01/2013 - 01/2006
4	ninjin'yoeitoIBA 06/2022 - 10/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2020 - 10/2015
3	PlatinumIBA 10/2017 - 04/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2012 - 08/2007
3	Therapeutic UsesIBA 03/2012 - 01/2002
3	Glycogen Synthase Kinase 3 betaIBA 12/2009 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 01/2003
3	EnzymesIBA 08/2005 - 10/2002
2	liu-jun-zi-tangIBA 06/2022 - 05/2022
2	juzentaihotoIBA 06/2022 - 01/2013
2	Plant ExtractsIBA 06/2022 - 07/2006
2	bu-zhong-yi-qi-tangIBA 06/2022 - 05/2022
2	gosha-jinki-ganIBA 06/2022 - 05/2022
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022 - 12/2017
2	LipidsIBA 09/2020 - 03/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 01/2005
2	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 03/2011
2	saiko-keishi-to (TJ10)IBA 11/2014 - 01/2007
2	CytokinesIBA 01/2013 - 10/2010
2	Bortezomib (Velcade)FDA Link 12/2012 - 06/2011
2	Tumor Biomarkers (Tumor Markers)IBA 12/2012 - 04/2004
2	Biological ProductsIBA 10/2012 - 04/2004
2	Glycogen Synthase (Synthase I)IBA 03/2012 - 11/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012 - 12/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 10/2010
2	Tyrosine (L-Tyrosine)FDA Link 01/2011 - 11/2009
2	MicroRNAs (MicroRNA)IBA 01/2011 - 01/2010
2	imidazole mustard (BIC)IBA 01/2011 - 01/2010
2	Monoclonal AntibodiesIBA 12/2010 - 01/2003
2	Pancreatitis-Associated ProteinsIBA 01/2007 - 03/2003
1	shakuyaku-kanzoh-tohIBA 05/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	cabozantinibIBA 01/2022
1	ZonarolIBA 09/2021
1	Methionine (L-Methionine)FDA Link 09/2021
1	Choline (Choline Chloride)IBA 09/2021
1	MedetomidineIBA 09/2020
1	Ketamine FDA LinkGeneric 09/2020
1	Capecitabine (Xeloda)FDA Link 06/2020

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 05/2022 - 12/2007
17	Therapeutics 05/2022 - 01/2005
9	Kampo Medicine (Kampo) 06/2022 - 03/2010
4	Radiotherapy 01/2013 - 01/2011
2	Castration 09/2017 - 03/2011
1	Acupuncture Therapy 09/2020